title: Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer.
abstract: An immunohistochemical determination of the growth fraction (GF) with the Ki-67 monoclonal antibody has been performed in a prospective series of 140 patients with primary operable breast carcinoma. GF ranged from 0% to 43% Ki-67 stained cells with a median value of 8%. High GF (> 8%) was significantly associated with axillary node involvement (p = 0.006), aneuploidy (p = 0.008), histologic grade (p = 0.03), and S-phase fraction > 5% determined by flow cytometry (p = 0.01). After a median follow-up of 6 years, the univariate analysis did not show significant correlation between high GF and worse relapse-free survival (p = 0.10) or shorter overall survival. However, a multivariate analysis on relapse-free survival, performed in 127 comparable patients, showed that GF was an independent predictive factor (p = 0.03) together with nodal status (p = 0.00001), age under 45 years (p = 0.0008), and chemotherapy (0.006). In node negative patients, GF was still an independent prognostic indicator (p = 0.002) together with age under 45 years (p = 0.0003). Tumor proliferative activity evaluated by the monoclonal antibody Ki-67 appears to be an effective indicator of prognosis in breast cancer and could be of assistance in the decision making of adjuvant therapy in node negative patients.
authors: Laboratoire de Transfert, Institut Curie, Paris, France.
authors: J Y
authors: JY
authors: Pierga
authors: A
authors: A
authors: Leroyer
authors: P
authors: P
authors: Viehl
authors: V
authors: V
authors: Mosseri
authors: S
authors: S
authors: Chevillard
authors: H
authors: H
authors: Magdelénat
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000473:pathology*; D002455:Cell Division / Q000276:immunology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D019394:Ki-67 Antigen; D008875:Middle Aged; D015999:Multivariate Analysis; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D011379:Prognosis; D011446:Prospective Studies; D016196:S Phase; D013194:Staining and Labeling; D015996:Survival Rate
chemical_list: D019394:Ki-67 Antigen; D009363:Neoplasm Proteins; D009687:Nuclear Proteins